Evidence map›Paper›PMID 26800372›Full record

ArticleACS chemical neuroscience2016

Amyloid Plaque-Associated Oxidative Degradation of Uniformly Radiolabeled Arachidonic Acid.

Ran Furman, Ian V J Murray, Hayley E Schall, Qiwei Liu, Yonatan Ghiwot, Paul H Axelsen

Open access · greenAbstract read
In one paragraph

Article in ACS chemical neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Treating Alzheimer's disease by targeting iron.British journal of pharmacology · 2019
    Review
  7. Article
  8. Article
  9. Copper signalling: causes and consequences.Cell communication and signaling : CCS · 2018
    Review
  10. Article
  11. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2017
    Article
  12. Biosynthesis of uniformly labeledBioresource technology · 2017
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Ran FurmanDepartment of Pharmacology, The University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Ian V J MurrayDepartment of Neuroscience and Experimental Therapeutics, Texas A & M University , College Station, Texas 77807, United States.
Hayley E SchallDepartment of Neuroscience and Experimental Therapeutics, Texas A & M University , College Station, Texas 77807, United States.
Qiwei LiuDepartment of Pharmacology, The University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Yonatan GhiwotDepartment of Neuroscience and Experimental Therapeutics, Texas A & M University , College Station, Texas 77807, United States.
Paul H AxelsenDepartment of Pharmacology, The University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Texas A&M University · USUniversity of Pennsylvania · US

Funding

Structure determination by vibrational spectroscopyR01GM076201 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI AXELSEN, PAUL H · 2007 to 2018
$3.2M
Oxidative lipid stress in the brainR01NS074178 · NINDS · UNIVERSITY OF PENNSYLVANIA · PI AXELSEN, PAUL H · 2011 to 2015
$1.7M
NIGMS NIH HHS GM76201NIGMS NIH HHS R01 GM076201NINDS NIH HHS NS74178NINDS NIH HHS R01 NS074178
6 · The paper itself

Abstract

Oxidative stress is a frequently observed feature of Alzheimer's disease, but its pathological significance is not understood. To explore the relationship between oxidative stress and amyloid plaques, uniformly radiolabeled arachidonate was introduced into transgenic mouse models of Alzheimer's disease via intracerebroventricular injection. Uniform labeling with carbon-14 is used here for the first time, and made possible meaningful quantification of arachidonate oxidative degradation products. The injected arachidonate entered a fatty acid pool that was subject to oxidative degradation in both transgenic and wild-type animals. However, the extent of its degradation was markedly greater in the hippocampus of transgenic animals where amyloid plaques were abundant. In human Alzheimer's brain, plaque-associated proteins were post-translationally modified by hydroxynonenal, a well-known oxidative degradation product of arachidonate. These results suggest that several recurring themes in Alzheimer's pathogenesis, amyloid β proteins, transition metal ions, oxidative stress, and apolipoprotein isoforms, may be involved in a common mechanism that has the potential to explain both neuronal loss and fibril formation in this disease.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsArachidonic AcidChromatography, High Pressure LiquidDisease Models, AnimalFluorescent Antibody TechniqueHippocampusHumansMass SpectrometryMiceMice, TransgenicOxidative StressPlaque, AmyloidAmyloid beta-PeptidesArachidonic AcidAlzheimer’s diseaseOxidative stresspolyunsaturated fatty acids

Identifiers

PMID26800372
PMCPMC5654537
OpenAlexW2255742740

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.